ATAI Life Sciences NV (FRA:9VC) Accounts Payable & Accrued Expense : €10.00 Mil (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is ATAI Life Sciences NV Accounts Payable & Accrued Expense?

ATAI Life Sciences NV's quarterly accounts payable & accrued expense declined from Sep. 2024 (€14.16 Mil) to Dec. 2024 (€11.39 Mil) and declined from Dec. 2024 (€11.39 Mil) to Mar. 2025 (€10.00 Mil).

ATAI Life Sciences NV's annual accounts payable & accrued expense declined from Dec. 2022 (€17.94 Mil) to Dec. 2023 (€17.19 Mil) and declined from Dec. 2023 (€17.19 Mil) to Dec. 2024 (€11.39 Mil).

ATAI Life Sciences NV Accounts Payable & Accrued Expense Historical Data

The historical data trend for ATAI Life Sciences NV's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ATAI Life Sciences NV Accounts Payable & Accrued Expense Chart

ATAI Life Sciences NV Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

10.03

18.29

17.94

17.19

11.39

ATAI Life Sciences NV Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															12.78	14.57	14.16	11.39	10.00

ATAI Life Sciences NV Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

ATAI Life Sciences NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ATAI Life Sciences NV (FRA:9VC) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

ATAI:USA ATAI:Mexico 9VC:Germany

Address

Wallstrasse 16, Berlin, BB, DEU, 10179

Website

https://www.atai.life

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

ATAI Life Sciences NV Headlines

No Headlines